These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 9883970

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A, Urbańska-Ryś H, Robak T.
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T, Wierzbowska A, Błasińska-Morawiec M, Korycka A, Błoński JZ.
    Mediators Inflamm; 1999 May; 8(6):277-86. PubMed ID: 10815616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Similar serum levels of IL-6 and its soluble receptors in patients with HCV-related arthritis and rheumatoid arthritis: a pilot study.
    Riccio A, Postiglione L, Sabatini P, Linvelli M, Soriente I, Sangiolo MG, Amato P, Tarantino G.
    Int J Immunopathol Pharmacol; 2012 May; 25(1):281-5. PubMed ID: 22507342
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.
    Diaz-Torne C, Ortiz MDA, Moya P, Hernandez MV, Reina D, Castellvi I, De Agustin JJ, Fuente D, Corominas H, Sanmarti R, Zamora C, Cantó E, Vidal S.
    Semin Arthritis Rheum; 2018 Jun; 47(6):757-764. PubMed ID: 29157669
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interleukin-6, soluble interleukin-2-receptor and soluble interleukin-6-receptor in sera of patients with rheumatoid arthritis: influences of disease activity and drug therapy.
    Franke S, Herrmann D, Hein G, Müller A, Stein G.
    Eur J Med Res; 1997 Sep 29; 2(9):401-6. PubMed ID: 9300938
    [Abstract] [Full Text] [Related]

  • 14. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
    Ikeda K, Kinoshita M, Tagaya N, Shiojima T, Taga T, Yasukawa K, Suzuki H, Okano A.
    Brain Res; 1996 Jul 08; 726(1-2):91-7. PubMed ID: 8836549
    [Abstract] [Full Text] [Related]

  • 15. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
    Sherwin JR, Smith SK, Wilson A, Sharkey AM.
    J Clin Endocrinol Metab; 2002 Aug 08; 87(8):3953-60. PubMed ID: 12161539
    [Abstract] [Full Text] [Related]

  • 16. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.
    Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z.
    Arthritis Rheum; 1997 Jun 08; 40(6):1096-105. PubMed ID: 9182920
    [Abstract] [Full Text] [Related]

  • 17. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
    Polgár A, Brózik M, Tóth S, Holub M, Hegyi K, Kádár A, Hodinka L, Falus A.
    Med Sci Monit; 2000 Jun 08; 6(1):13-8. PubMed ID: 11208277
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.
    Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T.
    Blood; 2008 Nov 15; 112(10):3959-64. PubMed ID: 18784373
    [Abstract] [Full Text] [Related]

  • 20. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
    Mihara M, Kasutani K, Okazaki M, Nakamura A, Kawai S, Sugimoto M, Matsumoto Y, Ohsugi Y.
    Int Immunopharmacol; 2005 Nov 15; 5(12):1731-40. PubMed ID: 16102523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.